Clinical Trials: Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer

Clinical Trial: Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer

Sponsor and Collaborators

Roswell Park Cancer Institute
Pfizer

Contact
Contact: AskRPCI
1-877-275-7724
AskRPCI@roswellpark.org

Principal Investigator
Roberto Pili, MD Roswell Park Cancer Institute

ClinicalTrials.gov Identifier

NCT01061411
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs